Igalmi Side Effects

Generic name: dexmedetomidine

Medically reviewed by Drugs.com. Last updated on Mar 23, 2025.

Note: This document provides detailed information about Igalmi Side Effects associated with dexmedetomidine. Some dosage forms listed on this page may not apply specifically to the brand name Igalmi.

Applies to dexmedetomidine: intravenous solution.

Serious side effects of Igalmi

Along with its needed effects, dexmedetomidine (the active ingredient contained in Igalmi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking dexmedetomidine:

More common side effects

• blurred vision
• chest pain or discomfort
• confusion
• coughing
• dizziness
• dizziness, faintness, or lightheadedness when getting suddenly up from a lying or sitting position
• headache
• irregular, fast or slow, or shallow breathing
• nervousness
• pale or blue lips, fingernails, or skin
• pounding in the ears
• slow or fast heartbeat
• sweating
• trouble breathing
• unusual tiredness or weakness

Less common side effects

• bleeding gums
• bloody urine
• coughing that sometimes produces a pink frothy sputum
• coughing up blood
• drowsiness
• dry mouth
• extremely high fever or body temperature
• fast, pounding, or irregular heartbeat or pulse
• fever
• flushed, dry skin
• fruit-like breath odor
• increased hunger
• increased menstrual flow or vaginal bleeding
• increased thirst
• increased urination
• loss of appetite
• lower back or side pain
• mood or mental changes
• muscle cramps in the hands, arms, feet, legs, or face
• muscle spasms or twitching seizures
• nausea
• nosebleeds
• numbness and tingling around the mouth, fingertips, or feet
• pale, clammy skin
• paralysis
• prolonged bleeding from cuts
• red or black, tarry stools
• red or dark brown urine
• seizures
• stomach cramps
• swelling of face, fingers, legs, or ankles
• tremor
• unexplained weight gain or loss
• vomiting

Incidence not known

• chest tightness
• confusion as to time, place, or person
• frequent urination
• holding false beliefs that cannot be changed by fact
• increased volume of pale, dilute urine
• irritability
• no blood pressure
• pain or discomfort in the arms, jaw, back, or neck
• restlessness
• seeing, hearing, or feeling things that are not there
• shakiness
• sleepiness
• slow to respond
• slurred speech
• stomach pain
• stopping of the heart
• unconsciousness
• unusual excitement, nervousness, or restlessness
• weakness or heaviness of the legs
• yellow eyes or skin

Other side effects of Igalmi

Some side effects of dexmedetomidine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• anxiety
• constipation
• shaking

Incidence not known

• hives, itching, rash
• redness of the skin
• seeing flashes or sparks of light

For healthcare professionals

Applies to dexmedetomidine: intravenous solution, sublingual film.

Cardiovascular adverse events

• Very common (10% or more): Hypotension (56%), bradycardia (42%), systolic hypertension (28%), hypotension requiring intervention (28%), tachycardia (25%), hypertension requiring intervention (19%), hypertension (16%), diastolic hypertension (12%), tachycardia requiring intervention (10%)
• Common (1% to 10%): Atrial fibrillation, sinus tachycardia, myocardial ischemia or infarction, bradycardia requiring intervention
• Uncommon (0.1% to 1%): Ventricular tachycardia, atrioventricular block first degree, decreased cardiac output
• Frequency not reported: Sinus arrest
• Postmarketing reports: Arrhythmia, cardiac arrest, cardiac disorder, extrasystoles, supraventricular tachycardia, ventricular arrhythmia, electrocardiogram T wave inversion, prolonged QT, blood pressure fluctuation, heart block^[Ref]

Respiratory

• Very common (10% or more): Respiratory depression (37%)
• Common (1% to 10%): Atelectasis, hypoxia, pulmonary edema, pleural effusion, respiratory failure, acute respiratory distress syndrome, bradypnea, pneumonia, pharyngolaryngeal pain
• Uncommon (0.1% to 1%): Wheezing, dyspnea, apnea
• Frequency not reported: Decreased respiratory rate
• Postmarketing reports: Bronchospasm, hypercapnia, hypoventilation, pulmonary congestion, respiratory acidosis^[Ref]

Gastrointestinal

• Very common (10% or more): Nausea (11%)
• Common (1% to 10%): Dry mouth, vomiting, constipation, abdominal distension, abdominal pain, diarrhea^[Ref]

Dermatologic

• Common (1% to 10%): Decubitus ulcer
• Uncommon (0.1% to 1%): Rash
• Postmarketing reports: Hyperhidrosis^[Ref]

Hematologic

• Common (1% to 10%): Anemia
• Uncommon (0.1% to 1%): Thrombocytopenia^[Ref]

Metabolic

• Common (1% to 10%): Hypovolemia, hyperglycemia, hypoglycemia, hypocalcemia, acidosis, hypokalemia, hypomagnesemia, hypernatremia, hypophosphatemia
• Uncommon (0.1% to 1%): Metabolic acidosis, hypoalbuminemia, electrolyte imbalance
• Postmarketing reports: Hyperkalemia, acidosis^[Ref]

Nervous system

• Common (1% to 10%): Headache
• Postmarketing reports: Convulsion, dizziness, neuralgia, neuritis, speech disorder^[Ref]

Other

• Common (1% to 10%): Pyrexia, hyperthermia, chills, post-procedural hemorrhage, withdrawal event/syndrome, rigors, hyperpyrexia, pain, thirst, generalized edema, peripheral edema, sepsis, septic shock
• Uncommon (0.1% to 1%): Ineffective drug
• Frequency not reported: Tolerance, tachyphylaxis
• Postmarketing reports: Light anesthesia^[Ref]

Psychiatric

• Common (1% to 10%): Agitation, anxiety
• Uncommon (0.1% to 1%): Hallucination
• Postmarketing reports: Confusional state, delirium, illusion^[Ref]

Renal

• Common (1% to 10%): Acute renal failure, decreased urine output, oliguria
• Postmarketing reports: Increased blood urea, polyuria^[Ref]

Hepatic

• Postmarketing reports: Abnormal hepatic function, hyperbilirubinemia, increased ALT, increased AST, increased blood alkaline phosphatase, increased gamma-glutamyl transferase^[Ref]

Ocular

• Frequency not reported: Reduced lacrimation
• Postmarketing reports: Photopsia, abnormal vision, visual impairment^[Ref]

Further information

Igalmi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer